contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


bactiguard-holding-ab-publ-znn-bactiguard-trauma-nails-get-regulatory-approvals-in-japan

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Bactiguard is a global MedTech company that prevent infections related to medical devices. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation. Bactiguard operates through license partnerships with MedTech companies that apply the technology to their medical devices. The company also has a portfolio of wound management products. Bactiguard has its headquarters in Stockholm.

Bactiguard Holding

Since entering the initial license partnership with Zimmer Biomet, the ZNN Bactiguard trauma implants have been successfully launched across Europe, the Middle East and Africa. Today, Bactiguard...

<div class="abstract">Since entering the initial license partnership with Zimmer Biomet, the ZNN Bactiguard trauma implants have been successfully launched across Europe, the Middle East and Africa. Today, Bactiguard announces that regulatory approvals have been obtained on the coated trauma implants in Japan, facilitating an upcoming commercial launch into the Japanese trauma market (valued at approximately USD 540 million according to GlobalData).</div>Leading orthopedic company Zimmer Biomet and Bactiguard have been working together in partnership since 2019. The 2019 partnership gives Zimmer Biomet exclusivity to use Bactiguard's unique infection prevention coating technology on their orthopedic trauma implant product line. The technology is based on a thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The coating, which is fully biocompatible and environmentally friendly, is attached to the surface of the Zimmer Biomet's trauma implants to reduce the risk of infection.The regulatory approvals follow an extensive authorization process by the PMDA (Pharmaceutical and Medical Devices Agency) in Japan and manifest the value-add of Bactiguard's infection prevention coating technology.Anders Göransson, CEO of Bactiguard, comments "This is an important event for us, we are taking a first step into a new market within orthopedics, one of our key strategic therapeutic areas. The path to offer healthcare providers and patients in Japan our safe and effective infection prevention solutions, together with Zimmer Biomet, have now formally taken off. Going through such extensive and thorough approval process also shows the power of our partnership with Zimmer Biomet, the collaboration between our development teams has been great."Gaining product regulatory approvals in different markets is of strategic importance for Bactiguard. Regulatory approvals are the first step towards a full commercial launch of the ZNN Bactiguard trauma implants which is expected once the local healthcare authorities have committed to reimburse. These types of processes take time, and the Japanese regulatory approvals are anticipated to have limited impact on the Bactiguard Holding AB P&amp;L for 2023.

Bactiguard Holding AB (publ): ZNN Bactiguard trauma nails get regulatory approvals in Japan